Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial

BACKGROUND AND AIMS: This study assessed the efficacy of maintenance treatment with multimatrix mesalazine following achievement of complete or partial remission after induction treatment with high-dose multimatrix mesalazine. METHODS: In this phase 3b/4, open-label, multicentre, prospective, single...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubin, David T., Bradette, Marc, Gabalec, Libor, Dobru, Daniela, Márquez, Juan, Inglis, Susi, Magee, Elizabeth, Solomon, Dory, D’Haens, Geert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962361/
https://www.ncbi.nlm.nih.gov/pubmed/26908939
http://dx.doi.org/10.1093/ecco-jcc/jjw049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962361/
https://www.ncbi.nlm.nih.gov/pubmed/26908939
http://dx.doi.org/10.1093/ecco-jcc/jjw049

Ejemplares similares